Apr 10, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Viaskin Peanut was granted breakthrough therapy designation following positive Phase IIb results.
Apr 02, 2015
Pharmaceutical Technology
Emerging controlled-release technologies could lead to more effective therapies in the near future.
Mar 15, 2015
Pharmaceutical Technology
Taste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments.
Mar 02, 2015
Pharmaceutical Technology
While the skin offers an alternative route of administration for local and systemic drug delivery, developing semi-solid dosage forms can be a challenge.
Feb 23, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Bristol-Myers Squibb announced that it reached an agreement to acquire Flexus Biosciences and has entered into a $309-million partnership with Rigel Pharmaceuticals.
Feb 20, 2015
Celgene announced that its drug, Revlimid, gained FDA approval for the treatment of newly diagnosed multiple myeloma.
Feb 04, 2015
Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.
Jan 15, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Catalent Pharma Solutions and Sanofi-Aventis R&D have entered into a collaboration to develop Sanofi’s proprietary antibodies using Catalent’s SMARTag antibody drug conjugate (ADC) platform.
Jan 12, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Mexichem announced that it acquired the distribution and sale license for HFC-227ea/P from Du Pont.
Jan 02, 2015
Pharmaceutical Technology
Tocophersolan or TPGS was developed 60 years ago as a water-soluble form of vitamin E. The author gives an overview of TPGS, including its interesting properties, examples found in the literature, and a brief summary of the regulatory status and marketed formulations.
